Optinose

Intersect ENT

The company manufactures drug-eluting sinus implants for patients with chronic rhinosinusitis and healthcare professionals in the ear, nose and throat sector.

Aerin Medical

This company develops non-invasive radiofrequency devices for ear, nose and throat physicians to treat patients with nasal airway obstruction and chronic rhinitis.

Neurent Medical

This company develops radiofrequency ablation systems used by clinicians to treat chronic rhinitis by disrupting overactive nerves within the nasal cavity.

Paratek Pharmaceuticals

This company develops and commercialises antibiotics and nasal sprays for patients with infectious diseases, pneumonia, skin infections and chronic rhinosinusitis.

Dexterous Endoscopes

This company develops variable stiffness endoscopes for surgeons and hospitals to perform minimally invasive ear, nose and throat procedures.

AirNexis

This clinical-stage biotechnology company develops inhaled therapies for patients with chronic obstructive pulmonary disease and other respiratory conditions.

Pneumagen

This clinical-stage biotech company develops intranasal antiviral drugs to prevent and treat respiratory tract infections for patients with chronic lung diseases.

INEYE Therapeutics

This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.